Note: Funding Information: This work was supported by the Innovative Medicines Initiative Joint Undertaking (IMI JU) (Grant number 115523), Combatting Bacterial Resistance in Europe (COMBACTE), resources of which are composed of financial contribution from the European Union?s 7th Framework Programme (FP7/2007???2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies? in kind contribution. Funding Information: This work was supported by the Innovative Medicines Initiative Joint Undertaking (IMI JU) (Grant number 115523), Combatting Bacterial